Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Respiratory viral infections research, Monoclonal and Polyclonal Antibodies Research, Viral gastroenteritis research and epidemiology, and Influenza Virus Research Studies.
Functional and antigenic landscape of the Nipah virus receptor-binding protein
The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation
Computationally restoring the potency of a clinical antibody against Omicron
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein
Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
Potently neutralizing and protective human antibodies against SARS-CoV-2
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Broad dengue neutralization in mosquitoes expressing an engineered antibody
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein
High frequency of shared clonotypes in human B cell receptor repertoires
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice
Mxra8 is a receptor for multiple arthritogenic alphaviruses
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins